Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
RSC Advances|January 8, 2013
Evaluation of a symmetry-based strategy for assembling protein complexesDustin P Patterson, Ankur M Desai, Mark M Banaszak Holl, et al.
Analytical Methods : Advancing Methods and Applications|May 17, 2011
Acetonitrile shortage: use of isopropanol as an alternative elution system for ultra/high performance liquid chromatographyAnkur M Desai, Mark Andreae, Douglas G Mullen, et al.
Nanotechnology|August 6, 2010
HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAbRameshwer Shukla, Thommey P Thomas, Ankur M Desai, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2013
Design considerations for PAMAM dendrimer therapeuticsSascha N Goonewardena, Jeremy D Kratz, Hong Zong, et al.
Bioconjugate Chemistry|September 21, 2006
HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAbRameshwer Shukla, Thommey P Thomas, Jennifer L Peters, et al.
Molecular Pharmaceutics|July 26, 2012
Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeuticThommey P Thomas, Baohua Huang, Seok Ki Choi, et al.
Bioorganic & Medicinal Chemistry|April 5, 2011
Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agentYuehua Zhang, Thommey P Thomas, Kyung-Hoon Lee, et al.
Bioconjugate Chemistry|August 17, 2010
RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodiesDaniel Q McNerny, Jolanta F Kukowska-Latallo, Douglas G Mullen, et al.
Biomacromolecules|February 25, 2012
Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratioHong Zong, Thommey P Thomas, Kyung-Hoon Lee, et al.
ACS Nano|December 25, 2012
Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surfaceSeok Ki Choi, Andrzej Myc, Justin Ezekiel Silpe, et al.
Pageof 2